The Worst of 2025's Thanksgiving Leftover Stocks
When we launched the S&P 500′s Thanksgiving Leftover project the day after Thanksgiving 2025, we knew we were going to spend the next year following the stock prices of companies that weren’t doing very well. After all, to even make the list, the ten companies whose stocks we would track ranked as the S&P 500′s worst performing stocks of 2025.
In the nine months since then, a few of those stocks have outperformed the index, while the rest have lagged behind. Most of those stocks have fallen below their post-2025 Thanksgiving Day level, but not by anywhere near as much as they had fallen to qualify as one of the S&P 500′s worst performing stocks in 2025.
But one stock in particular has gone on to plumb new depths. It has continued to fall so much more that it is on track to qualify as one of the S&P 500′s worst performing stocks of 2026.
That stock is The Trade Desk (NASDAQ: TTD), the digital advertising firm analyst David Desjardins believes is facing an “existential crisis“. Here’s how he describes the company’s now nearly two year long fall from grace:
After reporting highly disappointing financial results for the second quarter of 2026, shares of The Trade Desk, Inc. (TTD) declined by a whopping 21.9% last Friday, which came on top of a 6.8% decline on the prior day. Since the publication of my initiating coverage in early February 2026, TTD’s stock price has basically been cut in half, from ~$27.00 per share at the time of publication to around $13.39 as of today’s market close.
Relative to its all-time high of $141.53 reached in December 2024, The Trade Desk has now declined by a massive ~90%. As David Einhorn famously said, a stock down 90% is just a stock that was down 80% before being cut in half again, and this is exactly what happened to TTD since last February. The depth of TTD’s sell-off is quite something, but what is even more impressive to me is its speed….
At this point, The Trade Desk has become one of the most hated stocks that I am aware of, and this is on top of being the worst-performing constituent in the S&P 500 (SPX) on a year-to-date basis. Pretty much everything said or written about the company is negative, and it is precisely why I decided to write an update today. In less than two years, TTD went from a market darling that could do no wrong at over 26.0x forward sales to being viewed as a melting ice cube changing hands at 2.3x forward sales today.
The following chart compares The Trade Desk’s stock performance with the S&P 500, from 29 November 2024 (aka “the day after Thanksgiving Day 2024) through 18 August 2026:
Believe it or not, despite the company’s continued misfortune, Desjardins views the company’s low stock price as a speculative strong buy opportunity, where he makes the argument that the company has some potential for a turnaround based on its available cash balance, lack of debt, and cash flow.
We disagree, because we think The Trade Desk has further to fall before it might reach that point.
Here’s why. According to SlickCharts, The Trade Desk’s market cap has fallen to where the company now ranks 502 out of the 503 stocks that make up the S&P 500 index. Because it has, and because its fall is continuing, the company’s stock is verging on the point where S&P will act to remove it from the index. If and when that happens, as increasingly seems likely, its stock price will experience the opposite of what happens when a company’s stock is included in the index, which is to say its stock price will fall even further.
A deeper decline is almost ensured given the negative outlook CEO Jeffrey Green communicated during the company’s 2026-Q2 earnings call. Gytis Zizys, who formerly held a buy rating for the company on the hope it will see a turnaround, reacted to that development:
The Trade Desk, Inc. (TTD) provided one of the worst guidances I’ve seen in recent months, which put the last nail in the coffin for many shareholders who were still clinging to the idea of a turnaround. It seems I was prematurely too bullish on the turnaround as well, and this report is forcing me to downgrade it to a hold. I don’t think there’s a point in selling at these low prices, unless you want to harvest some tax losses. If it gets to under $10 per share, I will be jumping in to see what happens over the next couple of years. It’ll either recover, or my investment will go to zero.
The only problem with this investing strategy is we can argue that the bar for being able to beat TTD’s stock performance is very low. It’s so low that investing almost anywhere else or just parking the money in a cash savings account would be more advantageous.
This article is a standalone feature in our ongoing Thanksgiving Leftover series, which will continue with its regular monthly installment later this month. The ongoing tragedy of the performance of The Trade Desk’s stock demanded a special edition.
Source: https://politicalcalculations.blogspot.com/2026/08/the-worst-of-2025s-thanksgiving.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.



